Stifel Nicolaus Lowers Quipt Home Medical (TSE:QIPT) Price Target to C$7.50

Quipt Home Medical (TSE:QIPTFree Report) had its price target trimmed by Stifel Nicolaus from C$8.40 to C$7.50 in a research report report published on Thursday morning,BayStreet.CA reports. The brokerage currently has a buy rating on the stock.

Quipt Home Medical Stock Performance

Shares of TSE QIPT opened at C$3.56 on Thursday. The business has a 50 day simple moving average of C$3.72 and a 200 day simple moving average of C$4.12. Quipt Home Medical has a 52 week low of C$3.28 and a 52 week high of C$6.98. The stock has a market cap of C$153.40 million, a price-to-earnings ratio of -20.94 and a beta of 1.01.

Quipt Home Medical Company Profile

(Get Free Report)

Quipt Home Medical Corp., through its subsidiaries, engages in the provision of durable and home medical equipment and supplies in the United States. The company offers nebulizers, oxygen concentrators, and CPAP and BiPAP units; traditional and non-traditional durable medical respiratory equipment and services; non-invasive ventilation equipment, supplies, and services; and engages in the rental of medical equipment.

Featured Stories

Receive News & Ratings for Quipt Home Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quipt Home Medical and related companies with MarketBeat.com's FREE daily email newsletter.